SLI
|
2 029,84
|
23,97
|
1,19 %
|
Analysen zu SLI-Werten
| 11:05 | Roche Buy | UBS AG | |
| 11:02 | Roche Underperform | Jefferies & Company Inc. | |
| 10:09 | Roche Underweight | JP Morgan Chase & Co. | |
| 07.11.25 | UBS Underweight | Barclays Capital | |
| 07.11.25 | ABB Neutral | Goldman Sachs Group Inc. | |
| 07.11.25 | Holcim Outperform | Bernstein Research | |
| 06.11.25 | Zurich Insurance Sell | UBS AG | |
| 06.11.25 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 06.11.25 | UBS Outperform | RBC Capital Markets | |
| 06.11.25 | Roche Underperform | Jefferies & Company Inc. | |
| 05.11.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 05.11.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 04.11.25 | Novartis Neutral | UBS AG | |
| 03.11.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 03.11.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.11.25 | Nestlé Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.10.25 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.10.25 | Novartis Buy | Deutsche Bank AG | |
| 31.10.25 | UBS Buy | Deutsche Bank AG | |
| 30.10.25 | UBS Buy | Deutsche Bank AG | |
| 30.10.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 29.10.25 | Novartis Kaufen | DZ BANK | |
| 29.10.25 | Novartis Buy | Deutsche Bank AG | |
| 29.10.25 | Novartis Neutral | UBS AG | |
| 29.10.25 | UBS Outperform | RBC Capital Markets | |
| 29.10.25 | UBS Buy | Jefferies & Company Inc. | |
| 29.10.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 29.10.25 | Novartis Hold | Jefferies & Company Inc. | |
| 28.10.25 | Novartis Hold | Jefferies & Company Inc. | |
| 28.10.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 28.10.25 | ABB Underperform | Bernstein Research | |
| 27.10.25 | Roche Outperform | Bernstein Research | |
| 27.10.25 | Novartis Outperform | Bernstein Research | |
| 27.10.25 | Novartis Hold | Jefferies & Company Inc. | |
| 27.10.25 | Swiss Re Underweight | Barclays Capital | |
| 27.10.25 | Roche Underperform | Jefferies & Company Inc. | |
| 27.10.25 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.10.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.10.25 | Roche Sell | Deutsche Bank AG | |
| 24.10.25 | Nestlé Market-Perform | Bernstein Research |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.